The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells
International Journal of Molecular Sciences · 16.10.2025 · 26 (20) · 10069
DOI: 10.3390/ijms262010069 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2025. Verfasst von Jacob Mora und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centro Científico y Tecnológico de Excelencia Ciencia & Vida, Fundación Ciencia & Vida, Avenida Del Valle Norte #725, Huechuraba, Santiago 8580702, C…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Receptors, Dopamine D3, Receptors, Dopamine D2, Colitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo de Chile, “Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia de ANID” Centro Ciencia & Vida, “Agencia Nacional de Investigación y Desarrollo de Chile (ANID)”.
Abstract (Originalsprache)
Since colonic dopamine levels are markedly reduced during inflammatory bowel disease (IBD), we investigated how dopamine affects regulatory T-cells (Treg), which critically limit gut inflammation. Previously, we showed that the stimulation of the high-affinity dopamine receptor D3 (Drd3) impairs suppressive Treg activity and limits their recruitment into the colon upon gut inflammation. Here we study the role of the low-affinity dopamine receptor Drd2 in Treg. We find that mice harbouring Drd2-deficient T-cells developed more severe colitis induced by dextran sodium sulphate. The stimulation of Drd2 potentiated the suppressive Treg activity and increased their ability to reach the colonic tissue. A transcriptomic analysis of intestinal mucosa from IBD patients revealed an association with increased DRD3 and reduced DRD2 expression. Bioluminescence resonance energy transfer assays revealed that Drd2 and Drd3 form a heteromer. An in situ proximity ligation assay indicated that the Drd2:Drd3 heteromer was expressed on colonic Treg, and its expression was increased upon inflammation. Using peptides analogous to the transmembrane (TM) segments from Drd2 and Drd3 in bimolecular fluorescence complementation assays, we found TM peptides able to disassemble this heteromer. The heteromer disassembly dampened the suppressive Treg activity and impaired the recruitment of Treg into the colon upon inflammation. Our findings indicate that the Drd2:Drd3 heteromer constitutes a dopamine sensor that regulates suppressive Treg activity and their colonic recruitment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Científico y Tecnológico de Excelencia Ciencia & Vida, Fundación Ciencia & Vida, Avenida Del Valle Norte #725, Huechuraba, Santiago 8580702, Chile.
- Facultad de Medicina, Universidad San Sebastián, Providencia, Santiago 7510156, Chile.
- Departmento de Bioquímica y Fisiología, Facultad de Farmacia y Ciencia de los Alimentos, Universidad de Barcelona, 08028 Barcelona, Spain.
- Fundación Arturo López Pérez OECI Cancer Center, Providencia, Santiago 7500921, Chile.
- Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Neuroimmunology and Regeneration of the Central Nervous System Unit, Biomedical Science Research Laboratory, Basic Sciences Department, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción 40…
ORCID-Profile: Iu Raïch, Gemma Navarro, Carolina Prado, Pia M Vidal, Ranko Gacesa, Rafael Franco, Rodrigo Pacheco
Förderung
- Agencia Nacional de Investigación y Desarrollo de Chile
- “Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia de ANID” Centro Ciencia & Vida
- “Agencia Nacional de Investigación y Desarrollo de Chile (ANID)”
Zitieren
APA
Mora, J., Raïch, I., Ugalde, V., Navarro, G., Prado, C., Vidal, P. M., Leal, P., Espinoza, A., Liu, M., Weersma, R., Gacesa, R., Hermoso, M. A., Franco, R., & Pacheco, R. (2025). The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells. International Journal of Molecular Sciences, 26(20), 10069. https://doi.org/10.3390/ijms262010069
Vancouver
Mora J, Raïch I, Ugalde V, Navarro G, Prado C, Vidal PM, et al. The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells. International Journal of Molecular Sciences. 2025;26(20):10069. doi:10.3390/ijms262010069
BibTeX
@article{Mora2025,
author = {Mora, Jacob and Raïch, Iu and Ugalde, Valentina and Navarro, Gemma and Prado, Carolina and Vidal, Pia M and Leal, Pedro and Espinoza, Alexandra and Liu, Moting and Weersma, Rinse and Gacesa, Ranko and Hermoso, Marcela A and Franco, Rafael and Pacheco, Rodrigo},
title = {The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {10069},
doi = {10.3390/ijms262010069}
}
EUVIMED